Physician profile
James Lusk
NPI 1992772941
$3,805.41
in general payments reported to CMS, 2019-2025
24 companies · $588 in 2025
The $588 reported for 2025 was more than what 81% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $541 · 2020: $502 · 2021: $527 · 2022: $323 · 2023: $607 · 2024: $717 · 2025: $588.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,742 · Entertainment: $170.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,741.99 |
| Entertainment | $169.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $959.70 | 2019-2025 | Lensx, Clareon, Argos |
| Abbvie INC. | $583.96 | 2022-2025 | |
| Allergan, INC. | $283.64 | 2019-2022 | |
| Glaukos Corporation | $258.99 | 2024 | Idose, Istent Trabecular Micro-Bypass System Model Is3 |
| Bausch & Lomb Americas INC. | $254.56 | 2023-2025 | Vyzulta, Xiidra, Miebo |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $236.95 | 2019-2021 | |
| Sun Pharmaceutical Industries INC. | $197.07 | 2020-2024 | Cequa |
| Optos, INC. | $169.87 | 2023 | Oct Ophthalmoscope, Panoramic Ophthalmoscope, Nfc-700 |
| Johnson & Johnson Surgical Vision, INC. | $135.47 | 2019-2025 | Tecnis Simplicity |
| Novartis Pharmaceuticals Corporation | $117.34 | 2020-2023 | |
| Oyster Point Pharma, INC. | $96.69 | 2022-2024 | Tyrvaya, Ryzumvi |
| Tarsus Pharmaceuticals, INC. | $95.71 | 2024-2025 | Xdemvy |
| Harrow Eye, LLC | $84.98 | 2024-2025 | Vevye |
| Kala Pharmaceuticals, INC. | $84.96 | 2019-2021 | |
| Rxsight INC | $65.15 | 2022-2024 | Rxsight Injector Handpiece, Rxsight Light Delivery Device (Ldd), Rxsight Injector Cartridge |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotissue Holdings INC. | $28.46 | 2023-2024 | |
| Aerie Pharmaceuticals, INC. | $26.84 | 2019 | |
| Thea Pharma INC. | $22.40 | 2023 | Iyuzeh |
| Carl Zeiss Meditec Ag | $19.40 | 2020 | |
| Horizon Therapeutics Plc | $18.41 | 2023 | Tepezza |
| Omeros Corporation | $16.88 | 2021 | |
| Zyla Life Sciences, INC. | $16.78 | 2019 | |
| Sight Sciences, INC. | $15.75 | 2022 | |
| Cardinal Health 200 LLC | $15.45 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Lusk listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.